查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808453

製药製造设备市场（按设备类型、技术、最终用户和应用）—2025-2030 年全球预测

Pharmaceutical Manufacturing Equipment Market by Equipment Type, Technology, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计製药製造设备市场规模到 2024 年将达到 192.2 亿美元，到 2025 年将达到 205.5 亿美元，到 2030 年将达到 289.1 亿美元，复合年增长率为 7.03%。

主要市场统计数据
基准年2024年 192.2亿美元
预计2025年 205.5亿美元
预计2030年 289.1亿美元
复合年增长率（%） 7.03%

製药生产设备是药物开发和生产的核心，能够将复杂的製剂转化为安全有效的治疗方法。随着产业面临不断变化的监管要求、日益增长的生技药品需求以及优化成本和上市时间等挑战，设备的选择和整合已成为关键的策略考量。各生产设施正在投资高精度压片压平机、先进的层析法套件以及支援无菌製程的先进生物反应器。这些投资不仅增强了製程控制和产品质量，还提高了适应个人化医疗和小规模生产所需的营运灵活性。

近年来，细胞疗法和基因疗法等新型治疗方法的推出进一步增强了专用发酵槽、一次性搅拌机和冷冻干燥机的作用，使其能够快速扩大规模。同时，传统的固态製剂系统也在不断发展，自动製粒机和流化床干燥机实现了更紧密的粒径分布和均匀的包衣。因此，生命科学公司优先考虑整合数位监控、预测性维护和模组化架构的设备解决方案。这种整体方法使生产线能够在不同的产品系列之间快速切换，同时保持严格的合规性。

展望未来，了解这些技术进步与不断变化的市场动态和法规环境之间的关係至关重要。下文检验重塑製药设备格局的变革性变化，并为评估新兴趋势的策略意义奠定基础。

应对颠覆性的技术和监管变化，重新定义製药设备的效率和扩充性

自动化、数位化和监管进步的整合正在推动製药设备产业的重大变革时期。融合人工智慧的自动化平台透过即时优化过程参数，简化了从胶囊填充到片剂包衣等复杂的工作流程。同时，资料驱动的品质源自于设计框架正在取代传统的批次放行通讯协定，从而实现主动控制策略，最大限度地减少偏差并确保产品属性的一致性。

评估2025年美国关税对製药设备供应链的多重影响

美国将于2025年实施新的关税，这将为製药设备的采购和部署带来巨大的复杂性。由于进口机械和关键耗材的关税上调，製造商面临更高的资本支出要求和更长的前置作业时间。这些成本压力迫使企业重新评估其供应商策略，并探索在免关税管辖区内实现流体化床干燥机、发酵槽和层析法装置的本地化生产的方案。

透过对设备、技术、最终用户和应用的详细细分来揭示关键市场动态

深入了解市场区隔对于规划製药设备产业的策略重点至关重要。在考虑设备类型时，必须考虑无菌处理设备、泡壳包装机、胶囊填充机、层析法设备、发酵槽和生物反应器、流体化床干燥机、製粒机、液体填充机、冷冻干燥机、搅拌机和片剂加工系统，其中片剂包衣机和压平机片机构成一个重要的子类别。技术细分进一步区分了可重复使用设备（因其使用寿命长、成本摊销低而受到重视）和一次性设备（其灵活性和清洗检验负担较轻）。

区域市场情报重点介绍美洲、欧洲、中东和非洲地区以及亚太地区的成长动力和战略机会

区域动态将在塑造製药製造设备产业的发展轨迹方面发挥关键作用。在美洲，强大的生物製药开发平臺和政府对国内生产的激励措施，刺激了对一次性生物反应器、层析法系统和冷冻干燥平台的强劲需求。北美领先的地区也在利用先进的分析和自动化技术对传统设施进行现代化改造，以延长设备生命週期并降低营运成本。

确定领先的製药製造设备供应商和影响行业竞争的策略性倡议

领先的设备供应商正透过有机创新、策略伙伴关係和定向收购等方式实现差异化。一些全球性公司正在透过收购利基市场无菌连接器和过滤装置製造商来扩展其一次性产品组合，为最终用户提供更全面的即插即用解决方案。其他公司则正在投资数位双胞胎平台和云端监控平台，使製程工程师无需进行实体测试即可模拟规模化生产场景并排除设备效能故障。

为行业领导者提供可行的策略和最佳实践，以提高营运敏捷性并推动永续成长

行业领导者必须优先考虑灵活性和数位化集成，才能保持竞争力。投资模组化一次性系统可以缩短验证週期，实现产品线之间的快速切换，并支持向个人化治疗的转变。先进的过程控制软体与硬体升级相辅相成，可即时查看关键参数，使团队能够主动预防偏差并保持一致的输出品质。

详述资料收集、检验和分析方法的综合研究途径，以支持研究的可信度

本研究采用严谨的研究框架，结合了原始访谈、二手资料分析和量化检验技术。专家与製程工程师、品质保证经理和采购主管的讨论，提供了关于设备性能、维护实务和策略性投资驱动因素的第一手见解。这些访谈，以及对行业出版物、技术规范和监管指南的广泛研究，确保了对市场趋势的全面了解。

总结见解，总结关键发现以及对全球製药设备相关人员的战略意义

本执行摘要强调了先进製药生产设备在支持稳健且高效的药品生产方面发挥的关键作用。探索从自动化和一次性技术到贸易政策影响的变革趋势，可以帮助产业相关人员更好地应对日益复杂的市场环境。細項分析揭示了按设备类型、技术偏好、最终用户类别和应用领域分類的不同需求概况，凸显了製定客製化策略的必要性。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 製药生产中对一次性技术的需求不断增加，以降低污染风险
  • 传统製造流程的日益普及正在改变全球製药设备产业的格局
  • 将物联网 (IoT) 整合到製药製造设备中，以实现即时监控和控制
  • 越来越关注能源​​效率和永续性设计
  • 利用人工智慧和机器学习优化製药生产工作流程
  • 引进先进的自动化技术，提高製药设备效率与精度
  • 开发可客製化、模组化的製药生产设备，满足多样化的生产需求
  • 灭菌技术的进步提高了药品生产的安全标准
  • 生物技术和个人化医疗的扩展将推动製造设备的创新
  • 法规遵从性影响製药製造设备标准与能力的演变

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章：製药製造设备市场（按设备类型）

  • 无菌加工设备
  • 泡壳包装机
  • 胶囊填充设备
  • 层析法设备
  • 发酵槽和生物反应器
  • 流体化流体化床干燥机
  • 製粒机
  • 液体填充机
  • 冷冻干燥设备
  • 搅拌机
  • 片剂加工设备
    • 片剂包衣机
    • 压片机

第九章：製药製造设备市场（依技术）

  • 可重复使用设备
  • 免洗设备

第 10 章：製药製造设备市场（依最终用户）

  • 契约製造组织
  • 製药公司
  • 研究和学术机构
  • 研究所

第 11 章製药製造设备市场（按应用）

  • 无菌灌装
  • 生物製药製造
  • 口服液体製造
  • 肠外生产
  • 固态剂型生产

第 12 章：美洲製药製造设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：欧洲、中东和非洲製药製造设备市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第十四章：亚太製药製造设备市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • ACG Pvt. Ltd.
    • ACIC Pharmaceuticals Inc.
    • Alfa Laval AB
    • Ambica Pharma Machines Pvt. Ltd.
    • GEA Group Aktiengesellschaft
    • Glatt GmbH
    • IDEX Corporation
    • IMA Group
    • Jinhu Ginhong Machinery Co., Ltd.
    • Komachine Inc.
    • Korber AG
    • Lee Industries
    • Maquinaria Industrial Dara, SL
    • Marchesini Group SpA
    • MG2 srl
    • Niverplast BV
    • Paul Mueller Company
    • Romaco Group
    • Shinva Medical Instrument Co., Ltd.
    • Solvay SA
    • Syntegon Technology GmbH
    • Thermo Fisher Scientific Inc.
    • UNITED PHARMATEK LLC

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-961BA04A2E92

The Pharmaceutical Manufacturing Equipment Market was valued at USD 19.22 billion in 2024 and is projected to grow to USD 20.55 billion in 2025, with a CAGR of 7.03%, reaching USD 28.91 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 19.22 billion
Estimated Year [2025] USD 20.55 billion
Forecast Year [2030] USD 28.91 billion
CAGR (%) 7.03%

Pharmaceutical manufacturing equipment sits at the heart of drug development and production, enabling the translation of complex formulations into safe, effective therapies. As the industry contends with evolving regulatory requirements, rising demand for biologics, and the imperative to optimize cost and time to market, equipment selection and integration have become critical strategic considerations. Facilities are investing in high-precision tablet presses, state-of-the-art chromatography suites, and advanced bioreactors that support aseptic processing. These investments not only enhance process control and product quality but also foster the operational flexibility needed to address personalized medicine and small-batch production.

In recent years, the entry of novel therapeutic modalities such as cell and gene therapies has further elevated the role of specialized fermenters, single-use mixers, and lyophilizers in enabling rapid scale-up. Meanwhile, traditional solid dosage systems have continued to evolve, featuring automated granulators and fluid bed dryers that deliver tighter particle size distribution and uniform coating. Consequently, life science companies are prioritizing equipment solutions that integrate digital monitoring, predictive maintenance, and modular architectures. This holistic approach ensures that manufacturing lines can pivot swiftly between diverse product portfolios while maintaining rigorous compliance.

Looking ahead, understanding how these technological advancements intersect with shifting market dynamics and regulatory environments will be essential. The following section examines the transformative shifts reshaping the pharmaceutical equipment landscape and sets the stage for assessing the strategic implications of emerging trends.

Navigating Disruptive Technological and Regulatory Transformations Redefining Pharmaceutical Equipment Efficiency and Scalability

The pharmaceutical equipment landscape is undergoing seismic transformation as advances in automation, digitalization, and regulatory expectations converge. Automation platforms embedded with artificial intelligence are streamlining complex workflows, from capsule filling to tablet coating, by optimizing process parameters in real time. Concurrently, data-driven quality by design frameworks are replacing traditional batch release protocols, enabling proactive control strategies that minimize deviations and ensure consistent product attributes.

Single-use technologies have moved beyond niche applications to become mainstream, particularly in biopharmaceutical manufacturing environments where contamination risks and cleaning validation costs drive demand for disposable systems. This shift has challenged equipment manufacturers to expand their portfolios to include sterile connectors, prevalidated assemblies, and modular fluid handling units. In parallel, continuous processing architectures are gaining traction for both small molecule and biologic production, promising reduced footprint, lower energy consumption, and improved yield stability.

Regulatory agencies across key markets are also reshaping the landscape. Recent guidance has emphasized process analytical technologies, real-time release testing, and lifecycle management practices, compelling equipment suppliers and end users to collaborate early in development. Supply chain resilience has emerged as another critical axis of transformation, with firms diversifying component sourcing and exploring nearshoring strategies to mitigate geopolitical uncertainties. Taken together, these disruptive forces are redefining efficiency, scalability, and risk management in pharmaceutical manufacturing.

Assessing the Multifaceted Consequences of United States Tariffs on Pharmaceutical Manufacturing Equipment Supply Chains in 2025

The implementation of new United States tariffs in 2025 has introduced significant complexity to the procurement and deployment of pharmaceutical manufacturing equipment. As duties increase on imported machinery and critical consumables, manufacturers have encountered rising capital expenditure requirements and extended lead times. These cost pressures have prompted organizations to reassess supplier strategies, exploring options to localize production of fluid bed dryers, fermenters, and chromatography units in tariff-free jurisdictions.

The ramifications extend beyond direct cost increases. Equipment vendors facing higher import duties are recalibrating pricing models and, in some cases, shifting inventory buffers to domestic warehouses. End users have responded by grouping orders into larger shipments to dilute tariff impacts or renegotiating long-term service contracts to secure fixed pricing. Meanwhile, the threat of further trade restrictions has accelerated interest in distributed manufacturing networks, where modular tablet processing and liquid filling systems can be deployed closer to end markets.

Despite these challenges, strategic adaptation has unlocked opportunities for equipment innovators. Firms that have invested in local engineering capabilities and decentralized assembly facilities are better positioned to maintain delivery timelines and preserve margins. Moreover, the tariffs have intensified collaboration between manufacturers and financial services providers, leading to creative leasing structures and equipment-as-a-service offerings that defer upfront capital outlay. Ultimately, navigating the 2025 tariff environment will demand agility, foresight, and the willingness to embrace alternative procurement models.

Uncovering Critical Market Dynamics through Detailed Equipment, Technology, End User, and Application Segmentation Insights

A nuanced understanding of market segmentation is essential to charting strategic priorities within the pharmaceutical equipment sector. When examining equipment types, one must consider aseptic processing equipment, blister packaging machines, capsule filling equipment, chromatography instruments, fermenters and bioreactors, fluid bed dryers, granulators, liquid filling machines, lyophilizers, mixers, and tablet processing systems, with tablet coating machines and tablet presses forming critical subcategories. Technology segmentation further distinguishes between reusable equipment-valued for its longevity and cost amortization-and single use equipment, which provides flexibility and reduced cleaning validation burdens.

End users span contract manufacturing organizations that deliver turnkey production services, pharmaceutical companies driving in-house manufacturing, research and academic institutes fostering early-stage innovation, and specialized research institutes focusing on advanced therapeutics. Application segmentation highlights the breadth of use cases, extending from aseptic filling operations to biopharmaceutical manufacturing, oral liquid production, parenteral processing, and solid dosage form creation. This layered segmentation framework reveals that demand drivers vary significantly by category: bioreactor and single-use mixer uptake is strongest in the biopharma segment, whereas granulators and tablet presses remain mainstays for solid dose players.

By aligning product development roadmaps with these segment dynamics, equipment providers can prioritize feature sets and geographic roll-out strategies that resonate most powerfully within each niche. Moreover, end users can tailor capital investments and maintenance programs according to the risk profile and regulatory intensity associated with their core applications.

Regional Market Intelligence Illuminating Growth Drivers and Strategic Opportunities across the Americas, EMEA, and Asia-Pacific Landscapes

Regional dynamics play a defining role in shaping the pharmaceutical manufacturing equipment sector's trajectory. In the Americas, strong biopharmaceutical R&D pipelines and government incentives for domestic production have stimulated robust demand for single use bioreactors, chromatography systems, and lyophilization platforms. Key hubs in North America are also leveraging advanced analytics and automation to modernize legacy facilities, thereby extending equipment lifecycles and reducing operational expenditures.

The Europe, Middle East & Africa region exhibits a more diverse set of drivers. Western European markets continue to lead in continuous processing adoption and integration of industry 4.0 solutions, supported by stringent regulatory regimes that emphasize quality by design. In contrast, emerging markets across the Middle East and Africa are investing in blister packaging and liquid filling lines to meet growing generic drug demand, with local regulatory bodies gradually strengthening manufacturing standards to align with global best practices.

Asia-Pacific stands out for its rapid capacity additions and cost-competitive manufacturing base. Countries such as India and China are scaling up granulators, tablet presses, and fluid bed dryers to serve both domestic and export markets. Simultaneously, regional governments are offering incentives for advanced bioreactor installations and funding collaborative centers of excellence. Connectivity initiatives are also fostering cross-border partnerships that accelerate technology transfer and localize after-sales support.

Identifying Leading Pharmaceutical Manufacturing Equipment Providers and Their Strategic Initiatives Shaping Industry Competitiveness

Leading equipment providers are differentiating themselves through a mix of organic innovation, strategic partnerships, and targeted acquisitions. Several global firms have expanded their single-use portfolio by acquiring niche manufacturers of sterile connectors and filtration units, thereby offering end users more comprehensive plug-and-play solutions. Others have invested in digital twins and cloud-enabled monitoring platforms, allowing process engineers to simulate scale-up scenarios and troubleshoot equipment performance without physical trials.

Collaborations between technology specialists and research institutions are also on the rise, resulting in co-developed chromatography resins and advanced sensor arrays that deliver tighter process control. Meanwhile, certain legacy suppliers have focused on modular skid-based systems, enabling contract manufacturers to rapidly configure production lines for new molecule launches. Service differentiation has become equally important, with firms offering predictive maintenance contracts and embedded remote diagnostics that proactively address equipment health issues.

Competition is further intensified by emerging players from adjacent industries, such as semiconductor equipment vendors entering the bioprocessing space with precision fluidics and contamination control expertise. This dynamic landscape underscores the importance of agility, with top performers continually refining their go-to-market strategies and leveraging cross-segment insights to anticipate customer needs.

Actionable Strategies and Best Practices for Industry Leaders to Enhance Operational Agility and Drive Sustainable Growth

Industry leaders should prioritize flexibility and digital integration to remain competitive. Investing in modular, single-use systems can reduce validation cycles and enable rapid changeover between product lines, supporting a shift toward personalized therapies. Complementing hardware upgrades with advanced process control software will provide real-time visibility into critical parameters, allowing teams to preempt deviations and maintain consistent output quality.

Diversifying supply chains is equally essential in the current geopolitical climate. Establishing partnerships with regional equipment assemblers and adopting equipment-as-a-service models can mitigate exposure to tariffs and logistical disruptions. Additionally, engaging early with regulatory authorities to align on process analytical technology roadmaps can streamline approvals and reduce post-approval modifications.

Finally, fostering cross-functional collaboration between R&D, engineering, and operations teams will accelerate technology adoption and drive continuous improvement. By embedding a culture of innovation, organizations can harness data insights to refine workflows, optimize utility consumption, and scale capacity efficiently. This holistic approach balances cost discipline with agility, positioning firms to capitalize on emerging therapeutic trends and evolving market demands.

Comprehensive Research Approach Detailing Data Collection, Validation, and Analytical Methods Underpinning Study Credibility

This study was developed through a rigorous research framework combining primary interviews, secondary data analysis, and quantitative validation techniques. Expert discussions with process engineers, quality assurance managers, and procurement directors provided firsthand insights into equipment performance, maintenance practices, and strategic investment drivers. Supplementing these interviews, an extensive review of industry publications, technical specifications, and regulatory guidelines ensured a comprehensive understanding of market trends.

Data triangulation methods were applied to corroborate findings across multiple sources. Equipment shipment records, patent filings, and academic research outputs were cross-referenced to confirm technology adoption timelines. Furthermore, a structured scoring model evaluated vendor capabilities against criteria such as innovation pipeline strength, service network coverage, and digital platform maturity. This model enabled objective comparisons and highlighted areas of competitive differentiation.

Throughout the process, quality controls were maintained via iterative peer reviews and validation checkpoints. Analysts continuously refined assumptions, updated contextual factors, and solicited feedback from advisory board members with deep domain expertise. The result is a robust and transparent methodology that underpins the study's strategic recommendations and ensures actionable intelligence for decision makers.

Conclusive Insights Summarizing Key Findings and Strategic Implications for Global Pharmaceutical Equipment Stakeholders

This executive summary has highlighted the critical role of advanced pharmaceutical manufacturing equipment in supporting robust and efficient drug production. By exploring transformative trends-from automation and single-use technologies to trade policy impacts-industry stakeholders can better navigate an increasingly complex landscape. Segmentation analysis has illuminated distinct demand profiles across equipment types, technology preferences, end-user categories, and application areas, underscoring the need for tailored strategies.

Regional insights reveal that the Americas, EMEA, and Asia-Pacific each present unique growth drivers and challenges, whether it be biopharma innovation clusters, regulatory harmonization efforts, or cost-competitive capacity expansions. Competitive intelligence underscores the importance of strategic partnerships, digital service offerings, and modular system architectures in differentiating vendor propositions. Finally, actionable recommendations emphasize flexibility, supply chain diversification, and data-driven process control as key enablers of sustainable growth.

Armed with these findings, equipment providers and end users alike can make informed decisions that balance operational efficiency with technological agility. Embracing a holistic approach to equipment strategy will be essential to unlocking new opportunities, managing risk, and achieving long-term success in the evolving pharmaceutical manufacturing ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing demand for single-use technologies in pharmaceutical production to reduce contamination risks
  • 5.2. Rising adoption of continuous manufacturing processes transforming pharmaceutical equipment landscape globally
  • 5.3. Integration of Internet of Things (IoT) in pharmaceutical manufacturing equipment for real-time monitoring and control
  • 5.4. Increasing focus on energy-efficient and sustainable pharmaceutical manufacturing equipment designs
  • 5.5. Utilization of artificial intelligence and machine learning to optimize pharmaceutical manufacturing workflows
  • 5.6. Implementation of advanced automation technologies in pharmaceutical manufacturing equipment to enhance efficiency and precision
  • 5.7. Development of customizable and modular pharmaceutical manufacturing equipment to meet diverse production needs
  • 5.8. Advancements in sterilization technologies improving safety standards in pharmaceutical manufacturing
  • 5.9. Expansion of biotechnology and personalized medicine driving innovation in manufacturing equipment
  • 5.10. Regulatory compliance shaping the evolution of pharmaceutical manufacturing equipment standards and features

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Pharmaceutical Manufacturing Equipment Market, by Equipment Type

  • 8.1. Introduction
  • 8.2. Aseptic Processing Equipment
  • 8.3. Blister Packaging Machines
  • 8.4. Capsule Filling Equipment
  • 8.5. Chromatography Equipment
  • 8.6. Fermenters & Bioreactors
  • 8.7. Fluid Bed Dryers
  • 8.8. Granulators
  • 8.9. Liquid Filling Machines
  • 8.10. Lyophilizers
  • 8.11. Mixers
  • 8.12. Tablet Processing Equipment
    • 8.12.1. Tablet Coating Machine
    • 8.12.2. Tablet Press

9. Pharmaceutical Manufacturing Equipment Market, by Technology

  • 9.1. Introduction
  • 9.2. Reusable Equipment
  • 9.3. Single Use Equipment

10. Pharmaceutical Manufacturing Equipment Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Manufacturing Organizations
  • 10.3. Pharmaceutical Companies
  • 10.4. Research & Academic Institutes
  • 10.5. Research Institutes

11. Pharmaceutical Manufacturing Equipment Market, by Application

  • 11.1. Introduction
  • 11.2. Aseptic Filling
  • 11.3. Biopharmaceutical Manufacturing
  • 11.4. Oral Liquid Manufacturing
  • 11.5. Parenteral Manufacturing
  • 11.6. Solid Dosage Manufacturing

12. Americas Pharmaceutical Manufacturing Equipment Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Pharmaceutical Manufacturing Equipment Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Pharmaceutical Manufacturing Equipment Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. ACG Pvt. Ltd.
    • 15.3.2. ACIC Pharmaceuticals Inc.
    • 15.3.3. Alfa Laval AB
    • 15.3.4. Ambica Pharma Machines Pvt. Ltd.
    • 15.3.5. GEA Group Aktiengesellschaft
    • 15.3.6. Glatt GmbH
    • 15.3.7. IDEX Corporation
    • 15.3.8. IMA Group
    • 15.3.9. Jinhu Ginhong Machinery Co., Ltd.
    • 15.3.10. Komachine Inc.
    • 15.3.11. Korber AG
    • 15.3.12. Lee Industries
    • 15.3.13. Maquinaria Industrial Dara, S.L.
    • 15.3.14. Marchesini Group S.p.A.
    • 15.3.15. MG2 s.r.l.
    • 15.3.16. Niverplast B.V.
    • 15.3.17. Paul Mueller Company
    • 15.3.18. Romaco Group
    • 15.3.19. Shinva Medical Instrument Co., Ltd.
    • 15.3.20. Solvay S.A.
    • 15.3.21. Syntegon Technology GmbH
    • 15.3.22. Thermo Fisher Scientific Inc.
    • 15.3.23. UNITED PHARMATEK LLC

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHAI
  • FIGURE 24. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHSTATISTICS
  • FIGURE 25. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHCONTACTS
  • FIGURE 26. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 111. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 113. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 114. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 124. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 125. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 159. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 161. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 166. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 167. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 176. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 177. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 179. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 186. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 187. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 189. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 197. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 199. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 217. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 226. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 227. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 229. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 233. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 239. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 246. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 247. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 251. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 256. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 257. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 259. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 266. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 267. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 269. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 273. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 277. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT